Related Experiment Videos
A case of monosymptomatic hypochondriacal psychosis treated with olanzapine
1University of Maryland Medical System, Baltimore, Maryland 21201, USA. EWeintra@UMPSY.UMaryland.edu
Abstract
Objective:
To emphasize the availability of safer alternatives to currently standard therapy for monosymptomatic hypochondriacal psychosis (MHP).
Method:
We report a case of treatment of monosymptomatic hypochondriacal psychosis in an elderly woman with the atypical neuroleptic olanzapine.
Results:
Treatment with rather low doses of olanzapine led to complete resolution of delusional symptoms.
Conclusions:
Olanzapine, like other atypical neuroleptic agents, shows promise as a treatment for this syndrome, and it offers considerable safety and side-effect advantages over older agents.